Avelox

In the US, Avelox (moxifloxacin systemic) is a member of the drug class quinolones and is used to treat Anthrax, Anthrax Prophylaxis, Bacterial Infection, Bronchitis, Intraabdominal Infection, Pneumonia, Prostatitis, Sinusitis, Skin and Structure Infection, Skin Infection and Tuberculosis - Active.

US matches:

• Avelox


• Avelox Tablets


• Avelox I.V.


• Avelox ABC Pack


• Avelox Injection

UK matches:

• Avelox 400 mg/250 ml solution for infusion
• Avelox 400 mg film-coated tablets (SPC)

Ingredient matches for Avelox

Moxifloxacin

Moxifloxacin is reported as an ingredient of Avelox in the following countries:

• Austria


• Bulgaria


• Turkey

Moxifloxacin hydrochloride (a derivative of Moxifloxacin) is reported as an ingredient of Avelox in the following countries:

• Argentina


• Aruba


• Australia


• Austria


• Bahamas


• Barbados


• Belgium


• Belize


• Bermuda


• Bosnia & Herzegowina


• Canada


• Cayman Islands


• Chile


• China


• Colombia


• Costa Rica


• Croatia (Hrvatska)


• Czech Republic


• Denmark


• Dominican Republic


• Ecuador


• El Salvador


• Estonia


• Finland


• Greece


• Guatemala


• Haiti


• Honduras


• Hong Kong


• Hungary


• Indonesia


• Ireland


• Jamaica


• Japan


• Latvia


• Lithuania


• Luxembourg


• Malaysia


• Mexico


• Netherlands


• Netherlands Antilles


• New Zealand


• Nicaragua


• Panama


• Peru


• Philippines


• Poland


• Portugal


• Romania


• Russian Federation


• Serbia


• Singapore


• Slovakia


• Slovenia


• Suriname


• Sweden


• Taiwan


• Thailand


• Trinidad & Tobago


• United Kingdom


• United States


• Vietnam

International Drug Name Search

Glossary

SPC	Summary of Product Characteristics (UK)

Click for further information on drug naming conventions and International Nonproprietary Names.